Case Report: Hemolytic Anemia During Pegylated IFN-α2b Plus Ribavirin Treatment for Chronic Hepatitis C: Ribavirin Is Not Always the Culprit

Authors :: Raimondo Cerini
Francesco Borrelli
Ivan Gentile
L. Reynaud
Chiara Viola
Ciampi R
Marcello Piazza
Guglielmo Borgia
Source :: Journal of Interferon & Cytokine Research. 25:283-285
Publication Year :: 2005
Publisher :: Mary Ann Liebert Inc, 2005.
Abstract: A 53-year-old woman admitted to our department for histologically proven chronic hepatitis C had previously been treated with pegylated interferon-α2b (PEG-IFN) plus ribavirin. Combination therapy ...

Subjects :: Hemolytic anemia
Combination therapy
business.industry
Ribavirin
Immunology
Cell Biology
medicine.disease
Culprit
humanities
chemistry.chemical_compound
chemistry
Chronic hepatitis
Virology
medicine
business

Full Text Access

Tools